Stay informed on the latest in arthritis prevention, research, treatment and care with JointHealth™ express, Canada's trusted source for arthritis news. Delivered right to your inbox, this "breaking news" bulletin provides timely updates on key arthritis topics, including disease management, research breakthroughs, and treatment advancements. As the longest-running arthritis news source in Canada, JointHealth™ express provides you expert insights from patients and analysis from arthritis health care professionals to help you on your arthritis journey. Stay connected to the arthritis information that matters most.
Click here to see JointHealth™ express bulletins from 2023 and earlier.
Latest News
Arthritis At Home 232 – The emerging adult with rheumatic disease
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Ms. Natasha Trehan, Drs Michelle Batthish ...
Arthritis At Home 231 – Testing for the right things and research updates in arthritis
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Janet Pope, Professor of Medicine ...
Reminder: Let BC PharmaCare hear “Your Voice” on tofacitinib (Xeljanz® and generics) for the treatment of psoriatic arthritis or ankylosing spondylitis
Tofacitinib (Xeljanz® and generics) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By ...
Reminder: Take the ACE National Survey on Private Health Insurance Plans by June 30
Help us identify how effective private health insurance plans are in supporting your arthritis-related needs by sharing your experience in ...
Arthritis At Home 230 – A journey towards health equity and shared decision making
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Ms. Natasha Trehan, person living with ...
New blog post from Joint Journeys, life with arthritis by Carrie: Just below the surface
In her latest blog post, Carrie shares how she is preparing for a triathlon and an important lesson she learned ...
Arthritis At Home 229 – Clinical practice guidelines and interprofessional shared decision making
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Karine Toupin April, Associate Professor ...
Leading the Way in Rheumatology: Key Developments from EULAR 2024
June 15th – Day 4 – marked the end of EULAR 2024 and another successful annual meeting where arthritis researchers, ...
EULAR 2024 Recap: Innovations and Implications for Rheumatology
Title of the study: Myths vs Realities: An honest feedback from the scientific community on collaboration with patients partners in ...
From Research to Practice: Essential Learnings from the EULAR Annual Congress
Title of the study: Treat-to-target approach allows to induce sustained clinical remission in over 60% of patients with early axial ...
Let BC PharmaCare hear “Your Voice” on tofacitinib (Xeljanz® and generics) for the treatment of psoriatic arthritis or ankylosing spondylitis
Tofacitinib (Xeljanz® and generics) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By ...
Arthritis At Home 228 – Health Literacy in Arthritis Care in Canada: The Perspective of BIPOC Men
In this Arthritis At Home, Kelly Lendvoy, ACE’s VP of Communications & Public Affairs, speaks to ACE’s programs coordinator, Ellen ...
